Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Sangamo Therapeutics Inc. (SGMO)

9.085   0.195 (2.19%) 03-25 14:10
Open: 8.99 Pre. Close: 8.89
High: 9.27 Low: 8.76
Volume: 732,424 Market Cap: 929M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.852 - 9.9 9.9 - 9.948
Low: 8.72 - 8.775 8.775 - 8.83
Close: 8.787 - 8.875 8.875 - 8.962

Technical analysis

as of: 2019-03-25 1:32:54 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 11.31     One year: 12.40
Support: Support1: 8.17    Support2: 6.80
Resistance: Resistance1: 9.68    Resistance2: 10.62
Pivot: 9.70
Moving Average: MA(5): 9.43     MA(20): 9.66
MA(100): 10.86     MA(250): 13.79
MACD: MACD(12,26): -0.13     Signal(9): -0.10
Stochastic oscillator: %K(14,3): 25.01     %D(3): 32.18
RSI: RSI(14): 44.20
52-week: High: 22.90  Low: 6.26  Change(%): -59.2
Average Vol(K): 3-Month: 208511  10-Days: 114210

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SGMO has closed above bottom band by 11.3%. Bollinger Bands are 61.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to SGMO's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 04 Mar 2019 14:15:32 Z
Why Sangamo Therapeutics Lost 22.9% of Its Value in February

Thu, 21 Feb 2019 18:14:54 Z
Analysts Estimate Sangamo Therapeutics (SGMO) to Report a Decline in Earnings: What to Look Out for

Thu, 21 Feb 2019 16:13:44 Z
2 Frustrating Flops, Plus Welcome to the Wrinkle Wars

Wed, 20 Feb 2019 18:06:53 Z
First Week of SGMO April 18th Options Trading

Tue, 19 Feb 2019 17:12:03 Z
What's in Store for Sangamo (SGMO) This Earnings Season?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 102.27
Shares Float (M) 100.22
% Held by Insiders 2.00
% Held by Institutions 97.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.710
EPS Est. Current Year -0.820
EPS Est. Next Year -0.800
EPS Est. Next Quarter -0.220
Forward EPS -0.630
Book Value (p.s.) 2.730
PEG Ratio 0.48
Profit Margin -81.69
Operating Margin -88.87
Return on Assets (ttm) -15.6
Return on Equity (ttm) -24.6
Qtrly Rev. Growth 105.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 37.15
Levered Free Cash Flow (M) -44.58

Stock Valuations

P/E -12.97
P/E Growth Ratio 0.04
P/BV 3.37
P/S 1082651392.00
P/CF 25.35

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.